Bram Baert, global head of Regulatory Affairs at Lonza CHI, gives his perspective on the impact of the EC’s decision on the ...

Results from two studies conducted in collaboration between Nanoform & Takeda to present at US Drug Delivery & Formulation Summit: Helsinki, Finland Friday, September 12, 2025, 18 ...

Creador, a Kuala Lumpur-based private equity firm, is set to acquire a 7% stake in La Renon Healthcare for ₹800 crore, ...

The pharmaceutical industry was a standout performer in FY25, combining growth with resilience. The largest drug maker, Sun ...

The oral solid dosage contract manufacturing market offers opportunities due to the popularity of tablets and capsules, complex API demands, and outsourcing trends. Growth is driven by North American ...

At CPHI Frankfurt (28 to 30 October), innovative excipients by Lubrizol will be exhibited, pushing the boundaries of pharmaceutical advancements. These next-generation excipients are designed to ...

Viking Therapeutics, Inc. ( NASDAQ: VKTX) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 3:20 PM EDT ...

Eli Lilly dominates obesity and diabetes treatments with soaring tirzepatide sales and promising oral drug data. Find out why ...